Back to search

Article

CRISPR/Cas9 edited tumor-associated immune cells in cancer immunotherapy

2025-01-09

Abstract excerpt

Immuno-oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification. This review provides an overview of recent advancements in the application of CRISPR/Cas9-edit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f65c4ec1-bca4-5eba-b9d2-1b833dd9cf1f
DOI
10.22541/au.173639048.85724396/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR/Cas9 edited tumor-associated immune cells in cancer immunotherapyDOI 10.22541/au.173639048.85724396/v1
Select a neighboring publication to make it the new centre.